A Phase II Study of Toripalimab Plus Chemotherapy and Low-Dose Radiotherapy for Neoadjuvant Therapy-Refractory Esophageal Squamous Cell Carcinoma
Clinical trial NCT07272291 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07272291
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-25
- Primary completion
- 2027-12-25
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.